ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,885Medicare Part D Prescriptions Filled, Including Refills

Rank: 29 out of 97

$462K Total Retail Price of All Prescriptions

Rank: 30 out of 97

455 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 455 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 455 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 8,569 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
LEVOTHYROXINE SODIUM 689 672 1 1
SIMVASTATIN 427 419 2 2
LISINOPRIL 400 393 3 4
FUROSEMIDE 301 293 4 3
OMEPRAZOLE 267 256 5 5
POTASSIUM CHLORIDE 248 244 6 10
METOPROLOL SUCCINATE 208 196 7 8
AMLODIPINE BESYLATE 180 180 8 6
WARFARIN SODIUM 168 168 9 11
LOSARTAN POTASSIUM 159 157 10 13
CITALOPRAM HBR 153 153 11 20
TRAMADOL HCL 152 150 12 21
METOPROLOL TARTRATE 150 141 13 7
HYDROCHLOROTHIAZIDE 147 144 14 9
GLIMEPIRIDE 141 138 15 39
QUINAPRIL HCL 131 124 16 146
JANTOVEN 105 105 17 37
ATENOLOL 104 93 18 15
DIGOXIN 100 97 19 26
METFORMIN HCL ER 95 92 20 89
TAMSULOSIN HCL 94 94 21 31
GABAPENTIN 90 87 22 18
SPIRONOLACTONE 88 84 23 33
SERTRALINE HCL 82 82 24 16
KLOR-CON 10 80 80 25 65
ADVAIR DISKUS 79 76 26 40
ATORVASTATIN CALCIUM 73 66 27 14
METFORMIN HCL 70 56 28 12
PREDNISONE 66 62 29 23
DOXYCYCLINE MONOHYDRATE 66 65 29 194
SPIRIVA 65 59 31 48
CELEBREX 62 61 32 95
CRESTOR 61 61 33 29
LOSARTAN-HYDROCHLOROTHIAZIDE 60 60 34 49
HYDROCODONE-ACETAMINOPHEN 59 59 S3 35 17
TRIAMTERENE-HCTZ 59 54 35 30
PANTOPRAZOLE SODIUM 57 57 37 53
DONEPEZIL HCL 57 57 37 24
CARVEDILOL 54 51 39 25
LANTUS 53 51 40 43
CLOPIDOGREL 52 51 41 34
LANTUS SOLOSTAR 52 32 41 41
BENAZEPRIL HCL 51 51 43 109
FLUOXETINE HCL 50 46 44 63
ALLOPURINOL 50 50 44 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 10, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.